These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24309956)

  • 1. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
    Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Gaggin HK; Bhardwaj A; Januzzi JL
    J Cardiovasc Transl Res; 2014 Mar; 7(2):250-61. PubMed ID: 24309956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure.
    Motiwala SR; Gaggin HK; Gandhi PU; Belcher A; Weiner RB; Baggish AL; Szymonifka J; Januzzi JL
    J Cardiovasc Transl Res; 2015 Apr; 8(3):164-72. PubMed ID: 25777344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?
    Gandhi PU; Gaggin HK; Sheftel AD; Belcher AM; Weiner RB; Baggish AL; Motiwala SR; Liu PP; Januzzi JL
    Am J Cardiol; 2014 Nov; 114(10):1543-9. PubMed ID: 25248814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.
    Gandhi PU; Gaggin HK; Redfield MM; Chen HH; Stevens SR; Anstrom KJ; Semigran MJ; Liu P; Januzzi JL
    JACC Heart Fail; 2016 Nov; 4(11):860-869. PubMed ID: 27744089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure.
    Jungbauer CG; Riedlinger J; Block D; Stadler S; Birner C; Buesing M; König W; Riegger G; Maier L; Luchner A
    Biomark Med; 2014; 8(6):777-89. PubMed ID: 25224934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea.
    Ibrahim NE; Afilalo M; Chen-Tournoux A; Christenson RH; Gaggin HK; Hollander JE; Kastner P; Levy PD; Mang A; Masson S; Nagurney JT; Nowak RM; Pang PS; Peacock WF; Dipl-Stat VR; Walters EL; Januzzi JL
    JACC Heart Fail; 2020 May; 8(5):415-422. PubMed ID: 32354416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative.
    Ferreira JP; Girerd N; Duarte K; Coiro S; McMurray JJ; Dargie HJ; Pitt B; Dickstein K; Testani JM; Zannad F; Rossignol P;
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28159825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.
    Ferreira JP; Packer M; Sattar N; Butler J; González Maldonado S; Panova-Noeva M; Sumin M; Masson S; Pocock SJ; Anker SD; Zannad F; Januzzi JL
    Eur J Heart Fail; 2024 Apr; 26(4):806-816. PubMed ID: 38587259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study.
    Meessen JMTA; Cesaroni G; Mureddu GF; Boccanelli A; Wienhues-Thelen UH; Kastner P; Ojeda-Fernandez L; Novelli D; Bazzoni G; Mangiavacchi M; Agabiti N; Masson S; Staszewsky L; Latini R;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):328. PubMed ID: 34217226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
    Gandhi PU; Chow SL; Rector TS; Krum H; Gaggin HK; McMurray JJ; Zile MR; Komajda M; McKelvie RS; Carson PE; Januzzi JL; Anand IS
    J Card Fail; 2017 Jan; 23(1):20-28. PubMed ID: 27317843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.
    Januzzi JL; Packer M; Claggett B; Liu J; Shah AM; Zile MR; Pieske B; Voors A; Gandhi PU; Prescott MF; Shi V; Lefkowitz MP; McMurray JJV; Solomon SD
    Circ Heart Fail; 2018 Oct; 11(10):e005133. PubMed ID: 30354399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial.
    Ueland T; Aukrust P; Nymo SH; Kjekshus J; McMurray JJ; Wikstrand J; Block D; Zaugg C; Gullestad L
    J Card Fail; 2015 Feb; 21(2):153-9. PubMed ID: 25451704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs Associated With Reverse Left Ventricular Remodeling in Humans Identify Pathways of Heart Failure Progression.
    Shah R; Ziegler O; Yeri A; Liu X; Murthy V; Rabideau D; Xiao CY; Hanspers K; Belcher A; Tackett M; Rosenzweig A; Pico AR; Januzzi JL; Das S
    Circ Heart Fail; 2018 Feb; 11(2):e004278. PubMed ID: 29438982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive role of diastolic dysfunction and ventricular remodeling in asymptomatic subjects at increased risk of heart failure.
    Fabiani I; Pugliese NR; La Carrubba S; Conte L; Colonna P; Caso P; Benedetto F; Antonini-Canterin F; Citro R; Dini FL; Carerj S; Di Bello V;
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1231-1240. PubMed ID: 30815808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.
    Barroso MC; Kramer F; Greene SJ; Scheyer D; Köhler T; Karoff M; Seyfarth M; Gheorghiade M; Dinh W
    BMC Cardiovasc Disord; 2016 Oct; 16(1):199. PubMed ID: 27769173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure: pentraxin 3—a marker of diastolic dysfunction and HF?
    Kaess BM; Vasan RS
    Nat Rev Cardiol; 2011 May; 8(5):246-8. PubMed ID: 21448138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.